当前位置: X-MOL 学术J. Urol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
A Prospective Randomized Trial of Neoadjuvant Chemohormonal Therapy vs Hormonal Therapy in Locally Advanced Prostate Cancer Treated by Radical Prostatectomy.
The Journal of Urology ( IF 6.6 ) Pub Date : 2024-04-09 , DOI: 10.1097/ju.0000000000003876
Hongyang Qian 1 , Chenfei Chi 1 , Thibault Tricard 1, 2 , Yinjie Zhu 1 , Liang Dong 1 , Yanqing Wang 1 , Jianjun Sha 1 , Jiayi Wang 1 , Zehua Ma 1 , Yan Wang 1 , Jiazhou Liu 1 , Baijun Dong 1 , Jiahua Pan 1 , Wei Xue 1
Affiliation  

Benefits of docetaxel-based neoadjuvant chemohormonal therapy (NCHT) before radical prostatectomy (RP) remain largely unknown. We explored whether docetaxel-based NCHT would bring pathological benefits and improve biochemical progression-free survival (bPFS) over neoadjuvant hormonal therapy (NHT) in locally advanced prostate cancer.

中文翻译:

新辅助化学激素疗法与激素疗法在根治性前列腺切除术治疗的局部晚期前列腺癌中的前瞻性随机试验。

根治性前列腺切除术 (RP) 之前基于多西紫杉醇的新辅助化学激素治疗 (NCHT) 的益处仍然很大程度上未知。我们探讨了基于多西紫杉醇的 NCHT 是否会比新辅助激素治疗 (NHT) 为局部晚期前列腺癌带来病理学益处并改善生化无进展生存期 (bPFS)。
更新日期:2024-04-09
down
wechat
bug